Myles, David C.,Kushner, Peter J.,Harmon, Cyrus L.
申请号：
AU2016331065
公开号：
AU2016331065A1
申请日:
2016.09.29
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present disclosure provides tetrahydro-1H-pyrido[3,4-b]indole compounds or a pharmaceutically acceptable salt, solvate, hydrate, prodrug, stereoisomer, tautomer, rotamer, N-oxide and/or substituted derivative or, optionally in a pharmaceutical composition, for the modulation of disorders mediated by estrogen, or other disorders as more fully described herein.
